Perryas The Chemotherapy Source Book, now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practice of chemotherapy, and is meant to serve as a aone-stop shopa for information on choice of chemotherapeutic agents, treatment outlines, grading of side effects, and dose modification.Melanoma Res. 2004;14(4):295a299. ... Weber J. Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010). Oncologist . 2008 ... Kinetics of response to ipilimumab (MDX-010) in patients with stage III/ IV melanoma [abstract 8525].J Clin Oncol. ... A phase II multi-center trial of maintenance biotherapy (MBT) after induction concurrent biochemotherapy (BCT ) for patientsanbsp;...
|Title||:||Perry's The Chemotherapy Source Book|
|Author||:||Michael C. Perry, Donald C. Doll, Carl E. Freter|
|Publisher||:||Lippincott Williams & Wilkins - 2012-07-30|